CONMED Corporation (CNMD) Q2 2010 Earnings Call July 29, 2010 10:00 am ET Executives Joe Corasanti - President and CEO Rob Shallish - CFO Analysts Matt Miksic - Piper Jaffray Dalton Chandler - Needham & Company James Sidoti - Sidoti & Company Robert Goldman - CL King Valerie Brown - Alliance Bernstein PresentationOperator
Good day ladies and gentlemen and welcome to the second quarter 2010 CONMED earnings conference call. My name is Louisa and I will be your operator for today. (Operator Instructions) As a reminder this conference is being recorded for replay purposes. I would now like to turn the call over to Mr. Joe Corasanti, President and CEO of CONMED. Please proceed, sir. Joe Corasanti Thank you very much. Good morning everyone. Welcome to CONMED Corporation's second quarter 2010 earnings conference call. With me today is Rob Shallish, our Chief Financial Officer. After formal remarks the call will be opened for questions. Before we begin, let me remind you that during this call we will be making comments and statements regarding our financial outlook, which represents forward-looking statements that involve risks and uncertainties as those terms are defined under the Federal Securities laws. Our actual results may differ materially from our current expectations. Please refer to the risk factors and other cautionary factors in today's press release, as well as our SEC filings for more details on factors that may cause actual results to differ materially. You will also hear Rob and me refer to certain non-GAAP measurements during this discussion. While these figures are not a substitute for GAAP measurements, company management uses them to aid us in monitoring the company's ongoing financial performance from quarter-to-quarter and year-to-year on a regular basis and for benchmarking against other medical technology companies.